High materiality7/10
Ionis Pharmaceuticals price target lowered to $54 from $61 at BMO Capital
Why it may matterVerify against the original reporting
Bearish outlook due to target cut.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BMO lowers IONS target to $54; current price $58.09; priceChangeSinceSignal -2.38.
- Target $54; price $58.09
Key facts
- 01
Target: $54
- 02
Posted price: $58.09
- 03
Analyst firm: BMO Capital
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.